OpenFilings
Actinium Pharmaceuticals, Inc.
Form
8-K
Report Period
2022-12-30
Date Filed
2022-12-30
Time Filed
17:00:14
Document Analysis
Natural Language Processing
Recognized Type
Unidentified
Defined Term Format
Underlined
Italicized
Bold
Exhibits
CURRENT REPORT
FOURTH AMENDMENT TO THE ACTINIUM PHARMACEUTICALS, INC. 2019 PLAN
Filing on SEC Edgar